Search FDA's QSR Interpretation:     Advanced Search

 

 

 

 

 

 

 

Sec. 820.1 Scope.

 

Link to an amendment published at 69 FR 29829, May 25, 2004.

(a) Applicability. (1) Current good manufacturing practice (CGMP) requirements are set forth in this quality system regulation. The requirements in this part govern the methods used in, and the facilities and controls used for, the design, manufacture, packaging, labeling, storage, installation, and servicing of all finished devices intended for human use. The requirements in this part are intended to ensure that finished devices will be safe and effective and otherwise in compliance with the Federal Food, Drug, and Cosmetic Act (the act). This part establishes basic requirements applicable to manufacturers of finished medical devices. If a manufacturer engages in only some operations subject to the requirements in this part, and not in others, that manufacturer need only comply with those requirements applicable to the operations in which it is engaged. With respect to class I devices, design controls apply only to those devices listed in § 820.30(a)(2). This regulation does not apply to manufacturers of components or parts of finished devices, but such manufacturers are encouraged to use appropriate provisions of this regulation as guidance. Manufacturers of human blood and blood components are not subject to this part, but are subject to part 606 of this chapter.

Interpretation:

The applicability of Current good manufacturing practice (cGMP)are applicable to all medical devices of class II or higher and Class I devices as listed in § 820.30(a)(2).  This list includes Devices automated with computer software. 

This section indicates that the regulation does not apply to manufacturers of components or parts of finished devices, ...but are “encouraged” to use appropriate provisions. Note that a "Component" is defined in 820.3(c) of the Quality System (QS) regulation as any material, substance, piece, part, software, firmware, labeling, or assembly, which is intended to be included in the finished, packaged, and labeled device. For example, fasteners, blood tubing assemblies and labels are components. This definition excludes "manufacturing materials," which by definition, are not intended to be included as part of the finished, packaged, and labeled device.

(2) The provisions of this part shall be applicable to any finished device as defined in this part, intended for human use, that is manufactured, imported, or offered for import in any State or Territory of the United States, the District of Columbia, or the Commonwealth of Puerto Rico.

Interpretation:

It doesn’t matter if you are making this product in the US or outside of the US.  If the intention is to sell the product in America you will require following the Quality System Regulation.

(3) In this regulation the term “where appropriate” is used several times. When a requirement is qualified by “where appropriate,” it is deemed to be “appropriate” unless the manufacturer can document justification otherwise. A requirement is “appropriate” if nonimplementation could reasonably be expected to result in the product not meeting its specified requirements or the manufacturer not being able to carry out any necessary corrective action.

Interpretation:

This is an important piece of information.  It implies correctly that the FDA are humans that are open to discussion. The words “where appropriate” is may be frustrating for some who fail to see the benefit of having something open for discussion. In fact if you have any confusion as to whether or not a piece of legislation applies or if you are having trouble with the interpretation of regulation, then contact the FDA.  

  

 *** for more extensive look ---- Download our 328 page guide to Interpretation of FDA's QSR with QSIT Reference!

 

 

 

Reference: www.FDA.gov

 

The information provided here is for "public consumption" and is open to interpretation. MedicalDeviceSchool.com is not responsible for the content or the accuracy of the information. For all official interpretation and accuracy we ask that you consult the FDA's website directly and that you consult with your legal and regulatory experts on all matters of interpretation.